RxDoctor Payments Data

Manjulatha Badam, MD

Undersea and Hyperbaric Medicine · San Antonio, TXNPI 1417013368

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Organogenesis Inc. at 50.3% of the total.

$1,192in general payments, 2019–2025

Across 47 payments — averaging $25.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$600
  • Smith+Nephew$170
  • Revance Therapeutics, Inc.$139
  • Blueprint Medicines Corporation$87
  • Misonix Inc$64
  • Tactile Systems Technology Inc$42
  • plus $91 from 4 others

What the payments were for

  • Food & beverage$1,192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,192 in reported general payments places this provider in the 55th percentile of 59 undersea and hyperbaric medicine providers in Texas.

See all undersea and hyperbaric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$6,554,478
Medicare patients
156
Services billed
9,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$108
Levofloxacin16$55

Paid to pharmacies, not to this prescriber.

Other undersea and hyperbaric medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →